Bed Bath & Beyond (NASDAQ:BBBY) updated its FY 2019 earnings guidance on Wednesday. The company provided EPS guidance of $2.11-2.11 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.98. The company issued revenue guidance of $11.4-11.4 billion, compared to the consensus revenue estimate of $11.48 billion.
Several research firms have recently commented on BBBY. Citigroup cut their price objective on GrafTech International from $21.00 to $17.00 and set a buy rating for the company in a report on Monday, April 1st. Robert W. Baird initiated coverage on The Medicines in a report on Wednesday, March 27th. They set an outperform rating and a $80.00 price target for the company. JPMorgan Chase & Co. reaffirmed a sell rating on shares of Rolls-Royce Motor Cars in a report on Tuesday, March 26th. Zacks Investment Research raised Green Brick Partners from a sell rating to a hold rating in a report on Wednesday, April 10th. Finally, UBS Group reaffirmed a buy rating and set a $70.00 price target on shares of Lumentum in a report on Thursday, April 11th. Five analysts have rated the stock with a sell rating, fourteen have assigned a hold rating, two have given a buy rating and one has given a strong buy rating to the stock. The stock has a consensus rating of Hold and an average target price of $17.06.
Shares of NASDAQ BBBY traded up $0.08 during mid-day trading on Wednesday, reaching $11.52. The company had a trading volume of 10,600,150 shares, compared to its average volume of 6,736,862. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.62 and a current ratio of 1.88. Bed Bath & Beyond has a one year low of $10.46 and a one year high of $20.49. The firm has a market cap of $1.48 billion, a price-to-earnings ratio of 5.62, a price-to-earnings-growth ratio of 5.81 and a beta of 1.19. The company has a 50-day moving average price of $12.30.
Bed Bath & Beyond (NASDAQ:BBBY) last issued its quarterly earnings results on Wednesday, April 10th. The retailer reported $1.20 EPS for the quarter, topping the Zacks’ consensus estimate of $1.11 by $0.09. Bed Bath & Beyond had a positive return on equity of 9.77% and a negative net margin of 1.14%. The company had revenue of $3.31 billion for the quarter, compared to analysts’ expectations of $3.33 billion. During the same quarter last year, the business earned $1.48 earnings per share. Equities research analysts predict that Bed Bath & Beyond will post 1.97 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, October 15th. Investors of record on Friday, September 13th will be given a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 5.90%. Bed Bath & Beyond’s payout ratio is currently 33.17%.
About Bed Bath & Beyond
Bed Bath & Beyond Inc, together with its subsidiaries, operates a chain of retail stores. It sells a range of domestics merchandise, including bed linens and related items, bath items, and kitchen textiles; and home furnishings, such as kitchen and tabletop items, fine tabletop, basic housewares, general home furnishings, consumables, and various juvenile products.
Read More: Why is insider trading harmful?
Receive News & Ratings for Bed Bath & Beyond Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bed Bath & Beyond and related companies with MarketBeat.com's FREE daily email newsletter.